Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

BioProcess International
September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, USA
Book Now
Menu
Book
Key Sessions
Jon Coffman
PLENARY KEYNOTE: Integrated and Continuous Bioprocessing: what’s holding us back, and where do we go from here?
Astra Zeneca
Uwe Buecheler
PLENARY KEYNOTE: Reshaping Regulatory Frameworks for a Multi-Modality Manufacturing World
Passion Bio
Preeya Boppana
KEYNOTE: Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations
AstraZeneca
Christian Airiau, Ph.D
KEYNOTE: Accelerating Biologics Development Through Advanced Analytics and Digital Transformation
Sanofi
Todd McDevitt
Keynote Panel Discussion- Big Pharma’s Cell and Gene Therapies Wish List: Investment Priorities and Emerging Opportunities
Independent
keyboard_arrow_right

Agenda September 23, 2026: Main Conference Day One - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Agenda September 23, 2026: Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
6:30am - 7:15am
BWB Fitness Class
Showing 1 of 1 Streams
7:30am - 8:10am
Registration and Morning Coffee
Showing 1 of 1 Streams
8:10am - 8:15am
Welcome To BioProcess International Day 1
8:15am - 8:55am
PLENARY KEYNOTE: Reshaping Regulatory Frameworks for a Multi-Modality Manufacturing World
  • Uwe Buecheler - Ad Board Chair, Passion Bio
  • Rick Morris - Distinguished Fellow, Technology Strategy and Innovation, CTO, Cytiva
  • Joerg Ahlgrimm - CEO, SK Pharmteco
Showing 8 of 8 Streams
8:55am - 9:00am
Chairperson's Opening Remarks
  • Jacqualyn Schulman, Ph.D. - Principal Scientist, Cell Line Development & ‘Omics Biologics Development, Bristol-Myers Squibb
9:00am - 9:30am
Study on Galactosylation Modification of Monoclonal Antibodies Fc Region
  • Yang Mei - Senior Scientist, Johnson and Johnson
9:30am - 10:00am
Engineering Vector–Cell Line Development Workflows to Accelerate Biopharma Development
  • Dylan Frabutt - Research Scientist, Elanco
10:00am - 10:30am
Beyond Single Systems: Multi-Transposase Strategies for Complex Molecular Assembly and Modulated Expression
  • Gavin Barnard - Chief Scientific Officer, ATUM
8:55am - 9:00am
Chairperson's Opening Remarks
  • Yang Wu - Principal Scientist, Sanofi
9:00am - 9:30am
Data Automation and Model Predicted Control for Cell Culture
  • Alexander Wu - Associate Scientist, Amgen
9:30am - 10:00am
Seed Train Process Intensification Using Ultra-High Cell Density (UHCD) Banking to Enable Direct Inoculation and Reduce Seed Train Complexity
  • Rajlaxmi Deshpande - Associate Scientist II, BioProcess Development, Alexion Pharmaceuticals
10:00am - 10:30am
Comparative Study of Gamma and X-ray Irradiation on CHO Cell Culture Growth: Risk Analysis and Performance Evaluation
  • Samuel Dorey - Principal Scientist, Materials and Irradiations, Sartorius
8:55am - 9:00am
Chairperson's Opening Remarks
  • Garima Thakur - Staff Engineer, Regeneron Pharmaceuticals
9:00am - 9:30am
KEYNOTE: Process Intensification Leveraging Integrated Continuous Purification and Pionic – From Vision to Reality
  • Kevin Brower - Global Head of Purification Development, Sanofi
9:30am - 10:00am
Rapid Polishing Chromatography Optimization for Challenging Bispecific Antibodies Using Automated High Throughput Screening
  • Lei Wang - Principal Scientist, Gilead Sciences
10:00am - 10:30am
Rethinking Buffer Preparation: A Practical Framework for Improving Efficiency, Flexibility, and Total Cost of Ownership
  • Chineye Emeche - Technical Applications Manager, Avantor
8:55am - 9:00am
Chairperson's Opening Remarks
  • Yi Li - Principal AI Engineer, AbbVie
9:00am - 9:30am
KEYNOTE: Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations
  • Preeya Boppana - Director Manufacturing Science & Technology, AstraZeneca
9:30am - 10:00am
Advancing At-Line Analytics Through a Structured PAT Roadmap: An Industrial Case Study
  • Yuxiang (Henry) Zhao - Senior Scientist, Bristol-Myers Squibb
10:00am - 10:30am
Economic impact of process intensification strategies in biopharmaceutical manufacturing
  • Sean Muthian, Ph.D., MBA - Chief Scientific Officer, Cytiva
8:55am - 9:00am
Chairperson's Opening Remarks
  • Kevin Zen, PhD - Senior Director of CMC Technical Operations, Opthea
9:00am - 9:30am
Engineering Affordability into Biologics: Strategies to Reduce Manufacturing Complexity and COGS
  • Kumar Dhanasekharan, PhD - President and CEO, Gokyo Biosciences Inc.
9:30am - 10:00am
From Bench to Bioprocess: Overcoming Challenges in the Evolving Landscape of Plasmid Manufacturing for Cell and Gene Therapy
  • Alois Jungbauer - Professor, Dept. of Biotechnology, BOKU University (BOKU)
10:00am - 10:30am
Trace Element Prediction - Data-Driven Understanding and Control of Impurities in Cell Culture Media
  • Scott Wilson - Director of Raw Material & Manufacturing Innovation R&D, MilliporeSigma
Showing 1 of 1 Streams
10:30am - 11:00am
Morning Break
Showing 8 of 8 Streams
11:00am - 11:15am
Morning Break
11:15am - 11:45am
Please Move To Another Track
11:45am - 12:15pm
Doing More with Less: Statistically Validating Smaller Clone Screening Panels for Cell Line Development for Complex Molecules
  • Tania Chakraborty Kelly - Senior Scientist, Merck
12:15pm - 12:45pm
Establishment and Application of a Novel CHO Cell Line (CHO-MK) in Antibody Manufacturing Processes
  • Tomohiro Makino - Senior Director, Head of Cell Line Development at Bioprocess Technology Research Laboratory II, Daiichi Sankyo
11:00am - 11:15am
Morning Break
11:15am - 11:45am
Building Robust Chemically Defined Media Processes: A QbD Framework for Critical Material Attribute Risk Management
  • Hesam Mahjoubi - Senior Principal Scientist, Amgen
  • Wade Nudson - Strategic Implementation Manager, MilliporeSigma
11:45am - 12:15pm
A Numerical Optimization Framework for Cell Culture Media Rebalancing
  • Aditya Walvekar - Scientist, Genentech
12:15pm - 12:45pm
Boosting Productivity with Intensified N 1 Perfusion and High-Seed HILVOP Operation
  • Alaina Anand - Scientist, Upstream Process Development, Bioprocess R & D, Pfizer
11:00am - 11:15am
Morning Break
11:15am - 11:45am
Scientific, Sustainability and Product Quality Assessment to Reduce Buffer Consumption on Platform Chromatography Steps
  • Sarah Scully - Scientist, Purification Process Development, Pfizer
11:45am - 12:15pm
Process Development to GMP Implementation of Raman Spectroscopy as a PAT Tool for the Purification of Protein Based Therapeutics
  • Christina Passno - Senior Staff Engineer, Regeneron Pharmaceuticals, Inc.
12:15pm - 12:45pm
Digital Twin–Enabled Control of Ion Exchange Chromatography for Robust mAb Purification
  • Ran Chen - Associate Director of Process Development Downstream, Henlius Bioscience
11:00am - 11:15am
Morning Break
11:15am - 11:45am
Advancing Raman chemometric models: A path to scalable and reliable bioprocess real-time monitoring and control
  • Bingyu Kuang - Senior Scientist II, Abbvie
11:45am - 12:15pm
Transforming Biomanufacturing: Why Architecture Must Precede Analytics
  • Martin Kockx - Principal Manufacturing Systems Engineer, Vertex Pharmaceuticals
12:15pm - 12:45pm
Qualification of mechanistic models in biopharmaceutical process development
  • Till Briskot - Senior Scientist, Boehringer Ingelheim
11:00am - 11:15am
Morning Break
11:15am - 11:45am
Fireside Chat: If We’d Known Then What We Know Now: Hard Lessons from Novel Modalities in CMC
  • Alpana Naresh, Ph.D. - Chief Manufacturing Officer, Hinge Bio, Inc.
  • Siddhartha (Sidd) Shrivastava, PhD - SVP, Head of CMC and Global Technical Operations, Cue Biopharma
  • Yvette Stallwood - Senior Director, Head of Early Development Services, Lonza
  • Dan Stanton - Trade Media Relations Expert, Sartorius
11:45am - 12:15pm
Advancing dual-payload bispecific ADCs: Strategies to overcome process and quality challenges
  • Rose Xu - Vice President, Head of Global Quality, Altruist
12:15pm - 12:45pm
Downstream Process Adaptations for Molecules Beyond Platform Fit
  • Wei Lu - Senior Staff Engineer, Takeda Pharmaceuticals
Showing 1 of 1 Streams
12:45pm - 1:00pm
Transition To Lunch Presentations
Showing 8 of 8 Streams
1:00pm - 1:45pm
Reimagining Single-Use Chromatography: Simplicity, Consistency, and Control
  • Sushma Nayak Teichert - Senior Global Product Manager, Cytiva
1:00pm - 1:45pm
From Data to Process Confidence: Connecting Sartorius Capabilities Across the Drug Life Cycle
  • Charles Meadows - Senior Solutions Marketing Expert, Sartorius
1:00pm - 1:45pm
Biologic Stability Enhancement: Formulation Strategies and Excipients
  • Jinghan Li - Applications Scientist, Croda Inc.
1:00pm - 1:45pm
From Complexity to Confidence: Challenges and Strategies for Bispecific and Multispecific Antibody Development
  • Taeheui Lee - Vice President, Antibody Purification Process Development, Samsung Biologics
1:00pm - 1:45pm
Flow State: Using the NGC Chromatography System to Merge TFF and Chromatography into One Purification Workflow
  • Alex Baker-Williams, PhD - Senior Proteomics Field Application Scientist, Bio-Rad Laboratories
Showing 1 of 1 Streams
1:45pm - 1:55pm
Lunch Networking
Showing 7 of 7 Streams
1:55pm - 2:00pm
Chairperson's Remarks
  • Rui Zheng - Senior Scientist, Bristol-Myers Squibb
2:00pm - 2:30pm
Fast Tracking CHO Cell Line Development Using Integrated Engineering Strategies
  • Jacqualyn Schulman, Ph.D. - Principal Scientist, Cell Line Development & ‘Omics Biologics Development, Bristol-Myers Squibb
2:30pm - 3:00pm
Optimizing cell line development technologies for high-speed and efficient cell line engineering
  • Thomas Jostock, PhD - Associate Director, Novartis
3:00pm - 3:30pm
AI-Enabled Multivariate Clone Selection for Enhanced Cell Line Development
  • Rajesh Beri Ph.D. - Chief Development Officer, Wheeler Bio
3:30pm - 4:00pm
Afternoon Break and Grand Opening of the Exhibit Hall
1:55pm - 2:00pm
Chairperson's Remarks
  • Yang Wu - Principal Scientist, Sanofi
2:00pm - 2:30pm
Why pCO2 Matters: Gassing Strategy as a Critical Lever for Establishing a Predictive Scale-Down Model
  • Jesse Fisher - Senior Associate Scientist, Gilead
2:30pm - 3:00pm
PANEL DISCUSSION: Sensors for Robust Upstream Processes – When Sensors Help and When To Stop
  • Alex Williams - Scientist, Biologics Development, Bristol-Myers Squibb
  • Jacob Crowe, PhD - Associate Director of Technical Services, Hamilton Company
  • Bingyu Kuang - Senior Scientist II, Abbvie
  • Moritz von Stosch - Co Founding Partner, HINA Bioventures
3:00pm - 3:30pm
Simplifying custom media from development to GMP with an end-to-end approach
  • Duncan Omune - Senior Director of MSAT, Lonza
  • Sanjay Kumar - Senior Subject Matter Expert, Lonza Bioscience, USA
3:30pm - 4:00pm
Afternoon Break and Grand Opening of the Exhibit Hall
1:55pm - 2:00pm
Chairperson Remarks
  • Nathan Nicholes - Associate Director Downstream Process Development, Biogen
2:00pm - 2:30pm
PANEL DISCUSSION: Scaling Downstream Processes: From Lab to GMP Manufacturing
  • Alpana Naresh, Ph.D. - Chief Manufacturing Officer, Hinge Bio, Inc.
  • Jin Yu - Senior Scientist, Process Development Downstream, Amgen
  • Thomas Johnson, Ph.D. - Lecturer in Downstream Bioprocessing, UCL
  • Catherine Spanoudis - Scientist, Downstream Process Development, Forge Biologics
  • Arvind Kushwaha - Vice President -Quality, Kemwell Biopharma
2:30pm - 3:00pm
Evaluation of a High-Throughput Convective Chromatography Technology for Developing mRNA Affinity Purification
  • Daniel Yur - Senior Scientist, Merck
3:00pm - 3:30pm
Establishing a Robust and Scalable Flowthrough Polishing Strategy for Fragment Control Using Mixed-Mode Chromatography
  • Deekshith Vemireddy - Senior Manager, Downstream Process Development, Alvotech
3:30pm - 4:00pm
Afternoon Break and Grand Opening of the Exhibit Hall
1:55pm - 2:00pm
Chairperson Remarks
  • Yi Li - Principal AI Engineer, AbbVie
2:00pm - 2:30pm
Mechanistic AI Software for Intelligent Decision-Making in Genomic Medicine Process Development and Manufacturing
  • Irene Rombel - Co-Founder and CEO, BioCurie
2:30pm - 3:00pm
KEYNOTE: Accelerating Biologics Development Through Advanced Analytics and Digital Transformation
  • Christian Airiau, Ph.D - Global Head, Data Sciences, Sanofi
3:00pm - 3:30pm
Bridging the Gap Between Upstream and Downstream Process Automation by Integrating an Autosampling Solution and the Connected Lab
  • Joseph Hunziker - Process Characterization and Technology Scientist, Regeneron
  • David Hansen - Principal Engineer, MilliporeSigma
3:30pm - 4:00pm
Afternoon Break and Grand Opening of the Exhibit Hall
1:55pm - 2:00pm
Chairperson Remarks
  • Kevin Zen, PhD - Senior Director of CMC Technical Operations, Opthea
2:00pm - 2:30pm
Advancing Development of Complex Molecules: Industry Survey Insights on Readiness, Risk, and CMC Decision‑Making
  • Amber Petersen - R&D Manager, MilliporeSigma
2:30pm - 3:00pm
CMC challenges associated with highly potent and difficult-to-manufacture bispecific antibodies
  • Arvind Srivastava, Ph.D. - Senior Vice President, ThirdArcBio
3:00pm - 3:30pm
A Toolbox for Success: Processing and Formulating High Concentration Monoclonal Antibodies
  • Christopher Marlein - Senior Principal Scientist, Process Development, FUJIFILM Biotechnologies
3:30pm - 4:00pm
Afternoon Break and Grand Opening of the Exhibit Hall
Afternoon Break
Showing 2 of 2 Streams
4:00pm - 4:50pm
Afternoon Break and Grand Opening of the Exhibit Hall
4:00pm - 4:20pm
The Utility of Bioreactors in Undergraduate Education
  • Salil Desai - Assistant Professor, Biological Engineering, Douglas D. Schumann School of Engineering, Wentworth Institute of Technology
4:20pm - 4:40pm
Evaluating Alternative Approaches for AAV Capsid Quantification Across Serotypes
  • Sarah Kenney - Bioanalytical Scientist, MilliporeSigma
4:40pm - 4:50pm
16:40 - 17:00 High-Yield CHO-MK Cell Culture Through High-Density Seeding in DynaDrive™ Bioreactor
  • Riztyan , - General Manager, Chitose Laboratory Corp
Showing 3 of 3 Streams
4:50pm - 5:00pm
Chairperson’s Opening Remarks
  • Kevin Brower - Global Head of Purification Development, Sanofi
5:00pm - 5:45pm
PLENARY KEYNOTE: Integrated and Continuous Bioprocessing: what’s holding us back, and where do we go from here?
  • Jon Coffman - Executive Director of Bioprocess Technology and Engineering, Astra Zeneca
4:50pm - 5:00pm
Afternoon Break Continued
5:00pm - 5:45pm
CGT Exhibit Hall Roundtable Discussions
  • Roundtable 1: AI Revolution in CGT Manufacturing – Beyond the Hype: Where is it Having an Impact?

Leader: Thorsten Gorba, Vice President of Process Development at Aspen Neuroscience

  • Roundtable 2: Navigating IITs in China

Leader: Scott Jeffers, Chief Technology Officer at GenSight Biologics


  • Roundtable 3: Supply Chain Mastery: Architecting Success from Bench to Market


  • Thorsten Gorba - VP, Process & Analytical Development, Aspen Neuroscience, Inc.
  • Scott Jeffers - Chief Technology Officer, GenSight Biologics
4:50pm - 5:00pm
16:40 - 17:00 (Continued) High-Yield CHO-MK Cell Culture Through High-Density Seeding in DynaDrive™ Bioreactor
  • Riztyan , - General Manager, Chitose Laboratory Corp
5:00pm - 5:20pm
GBI Bio manufacturing
  • Jesse McCool - President and Chief Operating Officer, GBI Bio
5:20pm - 5:30pm
Accelerated Cell Line and Clone Development for Novel mono and multispecific Antibody FIH: An AuriCHO based Integrated CRDMO Platform
  • Gayathri Ramaswamy - Global Head of Discovery Services, Aurigene Pharmaceutical Services
5:30pm - 5:40pm
From High-Throughput Analysis to Process Monitoring: HORIBA Raman Solutions for Life Science Applications
  • Aashish Tuladhar - Spectrometer Products Supervisor, HORIBA Instruments Incorporated
5:40pm - 5:45pm
5:40-5:50 Modern Risk Mitigation for Critical Sample Collections
  • Lori A Ball - President of Strategic Endeavors, Astoriom
Showing 3 of 3 Streams
5:45pm - 7:15pm
Networking Drinks
7:15pm - 7:20pm
Close of Day One
5:45pm - 5:50pm
5:40 - 5:50 Astoriom (Continued) Modern Risk Mitigation for Critical Sample Collections
  • Lori A Ball - President of Strategic Endeavors, Astoriom
5:50pm - 6:30pm
Spacer
6:30pm - 7:00pm
PANEL: From Cambridge to Clinic: Biotech Founders Building in the World's Most Innovative Square Mile
  • Tricia Bitetto - Program Manager, Venture Café Cambridge, CIC
  • Edward Ahn - Chief Executive Officer, Medipost Inc.
  • Francesco Destro - Chief Technology Officer, BioCurie
6:00pm - 7:00pm
Start Up Slam

Head to the Start-Up Zone for Cocktails and Innovation! Uncover the latest developments from industry trailblazers:

BioCurie Inc – 6pm – 6.05pm

Biolinco – 6.05pm – 6.10pm

Bioscibex – 6.10pm – 6.15pm

Green Elephant – 6.15pm – 6.20pm

CATUG Biotechnology – 6.20pm – 6.25pm

CUVIA – 6.25pm – 6.30pm

Genefab - 6.30pm - 6.35pm

Onyx Biotech - 6.35pm - 6.40pm

Eversyn – 6.40pm – 6.45pm

TEK Optima – 6.45pm – 6.50pm

UMTR Co. 6.50pm – 6.55pm

InnoFluidics- 6.55pm – 7pm

Agenda September 22, 2026: Pre-Conference Day
NextAgenda September 24, 2026: Main Conference Day Two
Filter
Streams
Choose Day